—
RnRMarketResearch.com include Onychomycosis Pipeline Review, H2 2017 is new report. This report based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.Onychomycosis Pipeline report has and 10 Figures, Spread across 67 Pages Report Available at http://www.rnrmarketresearch.com/onychomycosis-tinea-unguium-pipeline-review-h2-2017-market-report.html .
Onychomycosis (Tinea Unguium) - Companies Involved in Therapeutics Development
Almirall SA, Arno Therapeutics Inc, Blueberry Therapeutics Ltd, Dermala Inc, Eisai Co Ltd, Helix BioMedix Inc, Hexima Ltd, Meiji Seika Pharma Co Ltd, Moberg Pharma AB, NAL Pharmaceuticals Ltd, Novabiotics Ltd, Novan Inc, Viamet Pharmaceuticals Inc
Onychomycosis is a chronic fungal infection of the nails caused by dermatophytes. Symptoms include thickened nail that is difficult to cut, brittle or ragged nail, discolored or unsightly nail and pain of the finger or toe with ordinary activities. Treatment includes antifungal medications and surgery.
Order a copy of this research report at http://www.rnrmarketresearch.com/contacts/purchase?rname=1141780 .
Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Onychomycosis (Tinea Unguium) (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Onychomycosis (Tinea Unguium) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Onychomycosis (Tinea Unguium) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Preclinical, Discovery and Unknown stages are 1, 2, 6, 3, 3 and 1 respectively.
Discount Available at http://www.rnrmarketresearch.com/contacts/discount?rname=1141780
Onychomycosis (Tinea Unguium) (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
List of Figures
Number of Products under Development for Onychomycosis (Tinea Unguium), H2 2017
Number of Products under Development by Companies, H2 2017
Number of Products by Top 10 Targets, H2 2017
Number of Products by Stage and Top 10 Targets, H2 2017
Number of Products by Mechanism of Actions, H2 2017
Number of Products by Stage and Mechanism of Actions, H2 2017
Number of Products by Routes of Administration, H2 2017
Number of Products by Stage and Routes of Administration, H2 2017
Number of Products by Molecule Types, H2 2017
Number of Products by Stage and Molecule Types, H2 2017
About Us:
RnRMarketResearch.com is your one stop market research and industry analysis reports' library providing business data and intelligence information on thousands of micro markets with global as well as regional coverage. Category focused research, country reports, company profiles, regional and global industry profiles and guides to premium reports offering extensive coverage of other 20+ industries are all available in our library of syndicated market research reports.
Contact Info:
Name: Ritesh Tiwari
Email: Send Email
Organization: RnRMarketResearch.com
Website: http://www.rnrmarketresearch.com/onychomycosis-tinea-unguium-pipeline-review-h2-2017-market-report.html
Release ID: 220391
Google
RSS